AirXpanders Revenue and Competitors
Estimated Revenue & Valuation
- AirXpanders's estimated annual revenue is currently $5.3M per year.
- AirXpanders's estimated revenue per employee is $310,059
- AirXpanders's total funding is $138.9M.
Employee Data
- AirXpanders has 17 Employees.
- AirXpanders grew their employee count by -6% last year.
AirXpanders's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. Cost Accountant | Reveal Email/Phone |
2 | President & CEO | Reveal Email/Phone |
3 | Sr. Production Control Lead | Reveal Email/Phone |
AirXpanders Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is AirXpanders?
AirXpanders Inc., founded in 2005, designs, manufactures and markets innovative medical devices to improve breast reconstruction. Headquartered in San Jose, California, AirXpanders is committed to providing patients and surgeons with best-in-class products that are made under strict design and quality standards. The company?s flagship product, the AeroForm Tissue Expander System, is used in patients undergoing two-stage breast reconstruction following mastectomy. The AeroForm Tissue Expander System is the first and only FDA-cleared, patient-controlled and needle-free tissue tissue expander. Instead of requiring weekly visits to the surgeon for saline injections to expand, the AeroForm is gradually filled with carbon dioxide (CO2). Using a wireless dosage controller, the patient independently inflates the expander in the comfort of her own home and is able to control the pace of expansion. AeroForm also has CE Mark and TGA (Australia) approval and is commercially available in Australia. AirXpanders? vision is to be the global leader in reconstructive surgery products and to become the standard of care in two-stage breast reconstruction.
keywords:Biotechnology$138.9M
Total Funding
17
Number of Employees
$5.3M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AirXpanders News
Sientra Inc. Silimed; Specialty Surgical Products Inc. AirXpanders Inc. Find additional highlights on the growth strategies adopted by vendors...
AirXpanders; Bohus BioTech AB; AbbVie Inc. Merz Pharma GmbH & Co. Merck KGaA; Bonash Medical; Bioha Laboratories; B. Braun Melsungen AG...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.2M | 17 | -32% | $10M |
#2 | $0.6M | 17 | -69% | $4M |
#3 | $1.5M | 17 | N/A | N/A |
#4 | $1.5M | 17 | N/A | N/A |
#5 | $1.5M | 17 | N/A | N/A |